Correlation Between Applied Molecular and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Applied Molecular and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Applied Molecular and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Applied Molecular Transport and Unicycive Therapeutics, you can compare the effects of market volatilities on Applied Molecular and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Applied Molecular with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Applied Molecular and Unicycive Therapeutics.
Diversification Opportunities for Applied Molecular and Unicycive Therapeutics
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Applied and Unicycive is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Applied Molecular Transport and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Applied Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Applied Molecular Transport are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Applied Molecular i.e., Applied Molecular and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Applied Molecular and Unicycive Therapeutics
Given the investment horizon of 90 days Applied Molecular Transport is expected to generate 0.9 times more return on investment than Unicycive Therapeutics. However, Applied Molecular Transport is 1.11 times less risky than Unicycive Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Unicycive Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 34.00 in Applied Molecular Transport on September 2, 2024 and sell it today you would lose (1.00) from holding Applied Molecular Transport or give up 2.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 8.06% |
| Values | Daily Returns |
Applied Molecular Transport vs. Unicycive Therapeutics
Performance |
| Timeline |
| Applied Molecular |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Unicycive Therapeutics |
Applied Molecular and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Applied Molecular and Unicycive Therapeutics
The main advantage of trading using opposite Applied Molecular and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Applied Molecular position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.| Applied Molecular vs. Aileron Therapeutics | Applied Molecular vs. Bio Path Holdings | Applied Molecular vs. Benitec Biopharma Ltd | Applied Molecular vs. Aerovate Therapeutics |
| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |